Skip to Content

LCI 1535 (Doxycycline monohydrate 75 mg)

Pill imprint LCI 1535 has been identified as Doxycycline monohydrate 75 mg.

Doxycycline is used in the treatment of chlamydia infection; acne; bacterial infection; upper respiratory tract infection; lyme disease (and more), and belongs to the drug classes miscellaneous antimalarials, tetracyclines. There is positive evidence of human fetal risk during pregnancy. Doxycycline 75 mg is not a controlled substance under the Controlled Substance Act (CSA).

Doxycycline monohydrate 75 mg LCI 1535
Doxycycline monohydrate
Imprint:
LCI 1535
Strength:
75 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous antimalarials
Tetracyclines
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Lannett Company Inc
National Drug Code (NDC):
00527-1535
Inactive Ingredients:
lactose anhydrous
microcrystalline cellulose
corn starch
silicon dioxide
magnesium stearate
polyvinyl alcohol
titanium dioxide
polyethylene glycol
magnesium silicate
D&C Yellow No. 10
FD&C Yellow No. 6
aluminum oxide

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide